Are you Dr. Everitt?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 35 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1061 Waterloo Rd
Berwyn, PA 19312Phone+1 484-919-0017Fax+1 609-730-4326- Is this information wrong?
Summary
- Dr. Daniel Everitt, MD is a geriatrician in Berwyn, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania.
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1979 - 1982
Harvard Medical SchoolClass of 1979
Certifications & Licensure
PA State Medical License 1991 - 2016
Publications & Presentations
PubMed
- 4 citationsPhase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers.Mengchun Li, George A Saviolakis, Wael El-Amin, Mamodikoe Makhene, Blaire Osborn, Jerry R Nedelman, Tian J. Yang, Daniel Everitt> ;Clinical Pharmacology in Drug Development. 2021 Jun 1
- 4 citationsAn Exposure-Response Perspective on the Clinical Dose of Pretomanid.Jerry R Nedelman, David H Salinger, Vishak Subramoney, Rob Woolson, Karen Wade, Mengchun Li, Daniel Everitt, Mendel Carl M, Mel Spigelman> ;Antimicrobial Agents and Chemotherapy. 2020 Dec 16
- 27 citationsClofazimine pharmacokinetics in patients with TB: dosing implicationsMahmoud Tareq Abdelwahab, Sean Wasserman, James C.M. Brust, Neel R. Gandhi, Graeme Meintjes, Daniel Everitt, Andreas H. Diacon, Rodney Dawson, Lubbe Wiesner, Elin M. S...> ;The Journal of Antimicrobial Chemotherapy. 2020 Nov 1
- Join now to see all
Press Mentions
Scientists Develop 'Groundbreaking' Cure for Drug-Resistant TuberculosisAugust 16th, 2019
‘Latent’ Tuberculosis? It’s Not That Common, Experts FindSeptember 20th, 2018
